Literature DB >> 33363648

EFFECT OF PUERARIN ON THE PROLIFERATION AND DIFFERENTIATION OF OSTEOBLASTS AND THE EXPRESSION OF TYPE I COLLAGEN mRNA IN A HIGH-GLUCOSE ENVIRONMENT.

X H Wang1, X W Shi1, X X Luo1, D H Zhang1.   

Abstract

OBJECTIVE: To investigate the effect of puerarin (Pue) on the proliferation and differentiation of osteoblasts and the expression of type I collagen(Coll I) mRNA in a high-glucose (HG) environment, and to provide evidence for the clinical treatment of diabetic osteoporosis(DOP). SUBJECTS AND METHODS: The proliferation of osteoblasts from three groups - the control group, the HS group, and the HG+Pue (10-8-10-6 M) group - was cultivated for 72 h and evaluated using the methyl thiazolyltetrazolium (MTT) assay.
RESULTS: The MTT values and the ALP activities in all experimental groups were significantly lower than those in the control group, and the MTT values and the ALP activities in the HG+Pue group were significantly higher than those in the HS group. Coll I mRNA expression in all experimental groups was significantly lower than that in the control group, while that in the HG+Pue group was significantly higher than that in the HG group.
CONCLUSIONS: The proliferation and differentiation of osteoblasts and the expression of Coll I mRNA were inhibited by high glucose, but Pue can increase the proliferation and differentiation as well as the expression of Coll I mRNA in the osteoblasts, indicating that Pue could be therapeutically beneficial against DOP. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  differentiation; osteoblast; proliferation; puerarin; type I collagen

Year:  2020        PMID: 33363648      PMCID: PMC7748237          DOI: 10.4183/aeb.2020.288

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  21 in total

1.  Improvement of ocular blood flow and retinal functions with puerarin analogs.

Authors:  B Xuan; Y H Zhou; R L Yang; N Li; Z D Min; G C Chiou
Journal:  J Ocul Pharmacol Ther       Date:  1999-06       Impact factor: 2.671

2.  Intervention effects of puerarin on blood stasis in rats revealed by a (1)H NMR-based metabonomic approach.

Authors:  Zhong Jie Zou; Zhong Hua Liu; Meng Juan Gong; Bin Han; Shu Mei Wang; Sheng Wang Liang
Journal:  Phytomedicine       Date:  2015-02-11       Impact factor: 5.340

Review 3.  Osteoporosis: a still increasing prevalence.

Authors:  Jean-Yves Reginster; Nansa Burlet
Journal:  Bone       Date:  2006-02       Impact factor: 4.398

Review 4.  Diabetes and osteoporosis.

Authors:  Alois Saller; Stefania Maggi; Giovanna Romanato; Paolo Tonin; Gaetano Crepaldi
Journal:  Aging Clin Exp Res       Date:  2008-08       Impact factor: 3.636

5.  Protecting mechanism of puerarin on the brain neurocyte of rat in acute local ischemia brain injury and local cerebral ischemia-reperfusion injury.

Authors:  Hong-ping Pan; Gao Li
Journal:  Yakugaku Zasshi       Date:  2008-11       Impact factor: 0.302

6.  Soy isoflavone: The multipurpose phytochemical (Review).

Authors:  Qinglu Wang; Xiaoyue Ge; Xuewen Tian; Yujun Zhang; Jie Zhang; Pingping Zhang
Journal:  Biomed Rep       Date:  2013-06-03

7.  Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment.

Authors:  Tzvetanka Petranova; Ivan Sheytanov; Simeon Monov; Rodina Nestorova; Rasho Rashkov
Journal:  Biotechnol Biotechnol Equip       Date:  2014-10-17       Impact factor: 1.632

8.  Puerarin promotes osteogenesis and inhibits adipogenesis in vitro.

Authors:  Nan Wang; Xinluan Wang; Wenxiang Cheng; Huijuan Cao; Peng Zhang; Ling Qin
Journal:  Chin Med       Date:  2013-08-21       Impact factor: 5.455

Review 9.  Osteoporosis, fractures, and diabetes.

Authors:  Peter Jackuliak; Juraj Payer
Journal:  Int J Endocrinol       Date:  2014-06-23       Impact factor: 3.257

10.  Puerarin partly counteracts the inflammatory response after cerebral ischemia/reperfusion via activating the cholinergic anti-inflammatory pathway.

Authors:  Xiaojie Liu; Zhigang Mei; Jingping Qian; Yongbao Zeng; Mingzhi Wang
Journal:  Neural Regen Res       Date:  2013-12-05       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.